CAMBRIDGE, Mass., Feb. 5, 2018 /PRNewswire/ -- TCR2 Therapeutics Inc. announced today that its Chief ScientificOfficer, Robert Hofmeister, Ph.D., has been invited to present at the prestigious Keystone Symposia Conference on Emerging Cellular Therapies: T Cells and Beyond being held February 11-15 in
Dr. Hofmeister's oral presentations will discuss rationales and mechanisms for the company's HLA-independent TRuC™-T cells and provide additional updates for TC-210, the company's lead program targeting mesothelin-positive solid tumors. TC-210 is advancing into the clinic later this year for solid tumor indications including ovarian, mesothelioma, cholangiocarcinoma, pancreatic and lung cancers.
Presentation at Keystone Symposia Conference
Presentation at Molecular Med Tri-Con Conference
About TCR2 Therapeutics
TCR2 Therapeutics is an immuno-oncology company that has pioneered a novel class of T cell therapies for solid tumors that utilize the full signaling power of complete T cell receptors (TCR). TCR2 has developed a unique proprietary TRuC™ platform which can reprogram the natural TCR complex to elicit rapid killing of cancer cells with persistence and low cytokine release. The company has demonstrated superior activity against several tumor targets in preclinical models compared to CAR T cells and will advance its lead program TC-210 into the clinic in 2018. TCR2 was founded in 2015 by Dr. Patrick Baeuerle and backed with a $44.5M Series A financing led by MPM Capital and F2 Ventures. It has since assembled a world-class team of immunotherapy experts and entrepreneurs located in the heart of Kendall Square in Cambridge, MA. For more information, please visit www.tcr2.com.
View original content:http://www.prnewswire.com/news-releases/tcr2-therapeutics-to-present-at-the-2018-keystone-symposia-conference-on-emerging-cellular-therapies-t-cells-and-beyond-300593654.html
SOURCE TCR2 Therapeutics
Subscribe to our Free Newsletters!
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...
Dizziness is a feeling of being faint or unsteady whereas Vertigo is a feeling that you or your ...View All